Sprint Bioscience signs agreement with Bayer HealthCare

Wednesday, July 29, 2015

Sprint Bioscience AB Signs agreement with Bayer HealthCare.

May receive up to about 190 million euros ($210.27 million) in potential pre-clinical, clinical and sales-based milestone payments, including initial upfront payment from Bayer on signing agreement.

 

reuters.com

TOP